| A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy (NCT05212935) | Federico II University | 2022-05-01 |
| Evaluation of an Infant Immunization Encouragement Program in Nigeria (NCT03870061) | GiveWell | 2018-07-01 |
| Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. (NCT05037435) | Limited Liability Company Pharm Aid | 2018-06-25 |
| A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine (NCT03483116) | Murdoch Childrens Research Institute | 2018-06-15 |
| Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam (NCT03367559) | Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products | 2018-02-08 |
| SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance (NCT03313128) | London School of Hygiene and Tropical Medicine | 2017-10-05 |
| Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study (NCT02542462) | Children's Hospital Medical Center, Cincinnati | 2015-11-01 |
| The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses (NCT02538211) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-09-01 |
| Does the Fecal Microbiome Influence Rotarix Immunogenicity (NCT02220439) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-09-01 |
| Vaccine Effectiveness of RV1 in a Naïve Population (NCT01467037) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2012-02-01 |
| Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants (NCT00757926) | Shantha Biotechnics Limited | 2009-09-01 |
| Rotavirus Vaccine Produced by Butantan Institute (NCT00981669) | Butantan Institute | 2009-03-01 |
| ROTATEQ™ Post-Marketing Surveillance in the Philippines (NCT01357174) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel (NCT00484952) | Hillel Yaffe Medical Center | 2007-09-01 |
| RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) (NCT00443846) | Merck Sharp & Dohme LLC | 2007-02-13 |
| Surveillance of Rotavirus Gastroenteritis in Children <5 Years (NCT01363726) | Soroka University Medical Center | 2005-10-01 |
| Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) (NCT00130832) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants (NCT00280111) | Society for Applied Studies | 2005-01-01 |
| Consistency Lots Vaccine Study (V260-009) (NCT00092456) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Dose Confirmation Efficacy Study (V260-007) (NCT00092443) | Merck Sharp & Dohme LLC | 2002-09-01 |
| To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV (NCT00346892) | GlaxoSmithKline | 2001-11-01 |
| Rotavirus Efficacy and Safety Trial (REST)(V260-006) (NCT00090233) | Merck Sharp & Dohme LLC | 2001-01-01 |